… The knowledge that cervical neoplasia are caused by human papillomavirus (HPV) infection
has led to the evaluation of its role in screening. We evaluated the accuracy of HPV testing …

… on clinician-obtained samples to the addition of screening for human papillomavirus (HPV),
its main causative agent. For HPV testing, self-sampling instead of clinician-sampling has …

The recommendation for cervical screening is that it should be based on human papillomavirus
(HPV) molecular testing. For all screening programs, attention to quality assurance is …

Objective: To assess anal oncogenic human papillomavirus (HPV) and anal cytology as
screening tests for detecting high-grade anal intraepithelial neoplasia (AIN 2+), as this is an …

… testing for human papillomavirus (HPV) DNA is being investigated for primary screening [ 2 ].
Vaginal samples, which can be self-collected, can also be tested for … Human papillomavirus …

Cervical cancer remains a significant public health concern, both at a global and a European
level. A number of new technologies such as diagnostic tests for human papillomavirus (…

As human papillomavirus (HPV) becomes accepted as the central cause of cervical cancer,
longitudinal studies are shifting focus away from causality to a more detailed investigation of …

… Human papillomavirus (HPV) testing on self-collected samples is a potential alternative to
HPV testing on clinician-collected samples, but non-inferiority of its clinical accuracy remains …

There is accumulating evidence that oropharyngeal squamous cell carcinomas (SCCs) that
harbour oncogenic human papillomavirus (HPV) are biologically distinct and have a better …

… Harms of HPV Testing Human papillomavirus testing could increase harms relative to cytology
by increasing the number of unnecessary colposcopies and downstream consequences …